Class 4 Medicines Defect Notification: Lexon UK Ltd, Moclobemide 150mg Tablets, El(25)a/50

Recall Summary Lexon UK Ltd's Moclobemide 150mg tablets in certain batches have Patient Information Leaflets (PILs) that are missing important updated safety information. This affects patients in the United Kingdom who received these batches. The MHRA has classified this as a Class III defect.

Recalling firm
Lexon UK Ltd
Reason
Lexon UK Ltd has informed the MHRA that the Patient Information Leaflet (PIL) in the cartons for the batches listed in this notification is missing important updated safety information.
Classification
Class III
Category
drug recall
Country
United Kingdom
Agency
UK Medicines and Healthcare products Regulatory Agency
Recall date
2025-11-25
Status
Ongoing
Distribution
United Kingdom

Official recall notice from UK Medicines and Healthcare products Regulatory Agency

Recall details on Nibble Recalls: https://trynibble.app/recalls/12786673-48b5-4461-a0ef-b091c8e34576